Screener
CRISPR Therapeutics CRSP Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Collaboration Revenue | $1M— | $0-100% | $0— | $0— | $0— | |
| Grant | $458K-47.1% | $864K+25.0% | $889K+47.7% | $892K+72.5% | $865K+71.6% |
FAQ
- How does CRISPR Therapeutics break its business down?
- CRISPR Therapeutics (CRSP) reports revenue by product across 2 parts — Collaboration Revenue and Grant. Each is extracted from the segment footnotes and tracked over time.
- Where does CRISPR Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in CRISPR Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
